Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect

Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4581

Title:	Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect
Authors:	Oo, S. Varghese, J. Noor, F. Tang, M. L. Laing, I. Prastanti, F. Holt, P. G. LeSouef, P. N. Sly, P. D.
Issue Date:	2017
Source:	Feb 139, (2), 2017, p. 703-705.e4
Pages:	703-705.e4
Journal:	J Allergy Clin Immunol
Abstract:	1097-6825Sly, Peter D Varghese, Julie Noor, Farhana Tang, Mimi L K Laing, Ingrid Oo, Steve Prastanti, Franciska LeSouef, Peter N Holt, Patrick G Letter Randomized Controlled Trial United States J Allergy Clin Immunol. 2017 Feb;139(2):703-705.e4. doi: 10.1016/j.jaci.2016.07.035. Epub 2016 Sep 13.
DOI:	10.1016/j.jaci.2016.07.035
Keywords:	Omalizumab/administration & dosage/adverse effects;Seasons;Severity of Illness Index;Humans;Female;Child;AdolescentAsthma/epidemiology/immunology/pathology/*prevention & control;Male
Type:	Article
Appears in Sites:	Children's Health Queensland Publications

24

checked on Mar 13, 2025

Check